BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 24923704)

  • 1. High prevalence of non-alcoholic fatty liver disease in the Chinese - results from the Hong Kong liver health census.
    Fung J; Lee CK; Chan M; Seto WK; Lai CL; Yuen MF;
    Liver Int; 2015 Feb; 35(2):542-9. PubMed ID: 24923704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender impacts on the correlations between nonalcoholic fatty liver disease and hypertension in a Chinese population aged 45-60 y.
    Li XD; Qiu BH; Su FC; Sun SX
    Clin Exp Hypertens; 2016; 38(7):639-643. PubMed ID: 27680771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography.
    Wong VW; Chu WC; Wong GL; Chan RS; Chim AM; Ong A; Yeung DK; Yiu KK; Chu SH; Woo J; Chan FK; Chan HL
    Gut; 2012 Mar; 61(3):409-15. PubMed ID: 21846782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced liver fibrosis predicts heart failure and hospitalizations in people with type 2 diabetes: A prospective cohort study from Hong Kong Diabetes Register.
    Kong AP; Lau ES; O CK; Luk AO; Yip TC; Chow EY; Kwok R; Lee HW; Wong GL; Ma RC; Chan HL; Wong VW; Chan JC
    Diabetes Res Clin Pract; 2023 Aug; 202():110825. PubMed ID: 37442241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population.
    Feng RN; Du SS; Wang C; Li YC; Liu LY; Guo FC; Sun CH
    World J Gastroenterol; 2014 Dec; 20(47):17932-40. PubMed ID: 25548491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of Lean Patients with Non-alcoholic Fatty Liver Disease in a Middle Income Country; Prevalence and Its Association with Metabolic Disorders: A Cross-sectional Study.
    Naderian M; Kolahdoozan S; Sharifi AS; Garmaroudi G; Yaseri M; Poustchi H; Sohrabpour AA
    Arch Iran Med; 2017 Apr; 20(4):211-217. PubMed ID: 28412824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of non-alcoholic fatty liver disease in Hong Kong: a population study with paired proton-magnetic resonance spectroscopy.
    Wong VW; Wong GL; Yeung DK; Lau TK; Chan CK; Chim AM; Abrigo JM; Chan RS; Woo J; Tse YK; Chu WC; Chan HL
    J Hepatol; 2015 Jan; 62(1):182-9. PubMed ID: 25195550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Association Between Nonalcoholic Fatty Liver Disease and Metabolic Abnormalities in The United States Population.
    Jinjuvadia R; Antaki F; Lohia P; Liangpunsakul S
    J Clin Gastroenterol; 2017 Feb; 51(2):160-166. PubMed ID: 27580477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diet-Quality Scores and Prevalence of Nonalcoholic Fatty Liver Disease: A Population Study Using Proton-Magnetic Resonance Spectroscopy.
    Chan R; Wong VW; Chu WC; Wong GL; Li LS; Leung J; Chim AM; Yeung DK; Sea MM; Woo J; Chan FK; Chan HL
    PLoS One; 2015; 10(9):e0139310. PubMed ID: 26418083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
    Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-alcoholic fatty liver disease (NAFLD) and significant hepatic fibrosis defined by non-invasive assessment in patients with type 2 diabetes.
    Sobhonslidsuk A; Pulsombat A; Kaewdoung P; Petraksa S
    Asian Pac J Cancer Prev; 2015; 16(5):1789-94. PubMed ID: 25773826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholecystectomy is independently associated with nonalcoholic fatty liver disease in an Asian population.
    Kwak MS; Kim D; Chung GE; Kim W; Kim YJ; Yoon JH
    World J Gastroenterol; 2015 May; 21(20):6287-95. PubMed ID: 26034364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary Patterns Modulate the Risk of Non-Alcoholic Fatty Liver Disease in Chinese Adults.
    Yang CQ; Shu L; Wang S; Wang JJ; Zhou Y; Xuan YJ; Wang SF
    Nutrients; 2015 Jun; 7(6):4778-91. PubMed ID: 26083112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Characteristic analysis of patients with type 2 diabetes mellitus combined with advanced stage chronic liver disease: a community population-based cross-sectional study in Heping District, Shenyang City (CHESS-LN 2101)].
    Lyu C; Fu WL; Gu Y; Wang LS; Wang XM; Liu X; Qian JM; Tao Z; Chen Y; Liu C; He RL; Guan X; Wang Y; Wang Y; Qi XL
    Zhonghua Gan Zang Bing Za Zhi; 2022 Nov; 30(11):1194-1200. PubMed ID: 36891697
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevalence and Profile of Fibrosis in Diabetic Patients with Non-alcoholic Fatty Liver Disease and the Associated Factors.
    Prasetya IB; Hasan I; Wisnu W; Rumende CM
    Acta Med Indones; 2017 Apr; 49(2):91-98. PubMed ID: 28790222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between non-alcoholic fatty liver with metabolic risk factors and brachial-ankle pulse wave velocity.
    Zhu WH; Fang LZ; Lu CR; Dai HL; Chen JH; Qiao QH; Chen LY
    World J Gastroenterol; 2015 Sep; 21(35):10192-9. PubMed ID: 26401084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of prediabetes and diabetes in children and adolescents with biopsy-proven non-alcoholic fatty liver disease.
    Nobili V; Mantovani A; Cianfarani S; Alisi A; Mosca A; Sartorelli MR; Maffeis C; Loomba R; Byrne CD; Targher G
    J Hepatol; 2019 Oct; 71(4):802-810. PubMed ID: 31279904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-alcoholic fatty liver disease: an expanding problem with low levels of awareness in Hong Kong.
    Leung CM; Lai LS; Wong WH; Chan KH; Luk YW; Lai JY; Yeung YW; Hui WM
    J Gastroenterol Hepatol; 2009 Nov; 24(11):1786-90. PubMed ID: 19686415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic Steatosis and Fibrosis in Type 2 Diabetes: A Risk-Based Approach to Targeted Screening.
    Poustchi H; Alaei-Shahmiri F; Aghili R; Nobarani S; Malek M; Khamseh ME
    Arch Iran Med; 2021 Mar; 24(3):177-186. PubMed ID: 33878875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diastolic dysfunction and cardiovascular risk in old subjects: possible association with NAFLD?
    Gianotti G; Cenni A; Bianchi G; Masetti M; Zappoli P; Muscari A; Zoli M;
    Arch Gerontol Geriatr; 2014; 58(2):188-95. PubMed ID: 24268461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.